NCT00192829Unknown不适用
Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 100
- 试验地点
- 2
研究概览
简要总结
The association between cancer and thrombosis is well known and the occurrence of thrombotic complications is commonly associated with poor prognosis. The aim os this study is to determine the possible value of hypercoagulable parameters as prognostic parameters in advanced non-small cell lung carcinoma (NSCLC).
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically or cytologically confirmed diagnosis of NSCLC.
- •normal serum bilirubin
- •informed concent to participate in the study
排除标准
- •anticoagulant therapy
- •infectious disease
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
Hypercoagulation Screening in CancerHealthy Blood DonorsMoli-sani SubjectsCancer PatientsNCT02622815A.O. Ospedale Papa Giovanni XXIII16,000
招募中
不适用
A Predictive Score for Arterial Thrombosis Associated With CancerCancerNCT05256329National and Kapodistrian University of Athens2,000
已完成
不适用
A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)Treatment of Venous Thromboembolism in Cancer PatientsNCT05112666Bayer2,601
Unknown
不适用
Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)CancerNCT00400504Rigshospitalet, Denmark500
招募中
1 期
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and PolymorphismsSolid TumorThromboembolismCardiovascular DiseasesImmune System DiseasesInflammatory DiseasesChemotherapyImmunotherapyCancerColon CancerProstate CancerBreast CancerHepatocellular CarcinomaLung CancerNCT06065592Lebanese University500